Evidence map›Paper›PMID 28051777›Full record

ArticleCirculation research2016

Glycosylation Signatures of Inflammation Identify Cardiovascular Risk: Some Glyc It Hot.

Patrick R Lawler, Samia Mora

Abstract readEditorialComment
In one paragraph

Article in Circulation research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Trial
  2. Association of Glycoprotein Acetylation With Carotid-Femoral Pulse Wave Velocity in Patients Receiving Maintenance Hemodialysis.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Glycosylation and Cardiovascular Diseases.Advances in experimental medicine and biology · 2021
    Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Patrick R LawlerFrom the Center for Lipid Metabolomics, Cardiovascular Division, and Preventive Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Samia MoraFrom the Center for Lipid Metabolomics, Cardiovascular Division, and Preventive Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. smora@partners.org.

Funding

Training Program in the Epidemiology of CVDT32HL007575 · NHLBI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI BURING, JULIE E., RIDKER, PAUL M. · 1985 to 2019
$5.0M
Total plasma and IgG glycomes, statin therapy and ASCVD eventsR01HL117861 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI MORA, SAMIA · 2013 to 2022
$3.8M
INTEGRATION OF METABOLOMICS AND GENOMICS DATA TO INVESTIGATE CARDIOVASCULAR RISKR03CA211815 · NCI · UNIVERSITY OF LAUSANNE · PI BERGMANN, SVEN · 2016 to 2016
$134k
NCI NIH HHS R03 CA211815NHLBI NIH HHS R01 HL117861NHLBI NIH HHS T32 HL007575
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cardiovascular DiseasesInflammationAtherosclerosisGlycosylationHumansPsoriasisRisk Factorsanti-inflammatory agentsatherosclerosisEditorialsinflammationmetabolomicspsoriasis

Identifiers

PMID28051777
PMCPMC5215843

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.